Jerome P. Richie
Richie, Jerome P.
VIAF ID: 77697118 (Personal)
Permalink: http://viaf.org/viaf/77697118
Preferred Forms
- 100 0 _ ‡a Jerome P. Richie
- 200 _ | ‡a Richie ‡b Jerome P.
- 100 1 _ ‡a Richie, Jerome P.
- 100 1 _ ‡a Richie, Jerome P.
- 100 1 _ ‡a Richie, Jerome P.
- 100 1 _ ‡a Richie, Jerome P.
-
-
-
-
4xx's: Alternate Name Forms (1)
Works
Title | Sources |
---|---|
Re: dynamic contrast-enhanced subtraction MRI for characterizing intratesticular mass lesions | |
Re: Early experience with contrast-enhanced ultrasound in the diagnosis of testicular masses: a feasibility study | |
Re: Exploring the Spectrum of Late Effects following Radical Orchidectomy for Stage I Testicular Seminoma: | |
Re: Expression of microRNAs of C19MC in Different Histological Types of Testicular Germ Cell Tumour | |
Re: Family History of Cancer and Risk of Paediatric and Young Adult's Testicular Cancer: A Norwegian Cohort Study | |
Re: Gene Expression Signatures Prognostic for Relapse in Stage I Testicular Germ Cell Tumours | |
Re: genomic characterization of testis cancer: association of alterations with outcome of clinical stage 1 mixed germ cell nonseminomatous germ cell tumor of the testis | |
Re: Germ Cell Tumors with Malignant Somatic Transformation: A Mayo Clinic Experience | |
Re: Global trends in testicular cancer incidence and mortality | |
Re: Identification of 19 New Risk Loci and Potential Regulatory Mechanisms Influencing Susceptibility to Testicular Germ Cell Tumor | |
Re: Incidence of second malignancies after external beam radiotherapy for clinical stage I testicular seminoma | |
Re: Interim 18F-Fluorodeoxyglucose Positron Emission Tomography for Early Metabolic Assessment of Response to Cisplatin, Etoposide, and Bleomycin Chemotherapy for Metastatic Seminoma: Clinical Value and Future Directions | |
Re: Is it Safe to Insert a Testicular Prosthesis at the Time of Radical Orchidectomy for Testis Cancer: An Audit of 904 Men Undergoing Radical Orchidectomy. | |
Re: Loss of Nuclear Functions of HOXA10 is Associated with Testicular Cancer Proliferation | |
Re: lymph node management in patients with paratesticular rhabdomyosarcoma: a population-based analysis | |
Re: Lymphovascular Invasion and Presence of Embryonal Carcinoma as Risk Factors for Occult Metastatic Disease in Clinical Stage I Nonseminomatous Germ Cell Tumour: A Systematic Review and Meta-Analysis | |
Re: Management of seminomatous testicular cancer: a binational prospective population-based study from the Swedish Norwegian testicular cancer study group | |
Re: Management Trends in Stage I Testicular Seminoma: Impact of Race, Insurance Status, and Treatment Facility | |
Re: MicroRNA miR-371a-3p-A Novel Serum Biomarker of Testicular Germ Cell Tumors: Evidence for Specificity from Measurements in Testicular Vein Blood and in Neoplastic Hydrocele Fluid. | |
Re: miR-223-3p Regulates Cell Growth and Apoptosis via FBXW7 Suggesting an Oncogenic Role in Human Testicular Germ Cell Tumors | |
Re: MRI in the Follow-up of Testicular Cancer: Less is More | |
Re: Multi-Institutional Assessment of Adverse Health Outcomes among North American Testicular Cancer Survivors after Modern Cisplatin-Based Chemotherapy. | |
Re: New Insights into Germ Cell Tumor Genomics | |
Re: New Insights on the Mechanisms Affecting Fertility in Men with Non-Seminoma Testicular Cancer before Cancer Therapy | |
Re: Organ preservation technique without ischemia in patients with testicular tumor | |
Re: Outcome of Men with Relapse after Adjuvant Carboplatin for Clinical Stage I Seminoma | |
Re: Paclitaxel, Ifosfamide, and Cisplatin Efficacy for First-Line Treatment of Patients with Intermediate- or Poor-Risk Germ Cell Tumors. | |
Re: Paratesticular Rhabdomyosarcoma: Importance of Initial Therapy. | |
Re: patterns of management and surveillance imaging amongst medical oncologists in Australia for stage I testicular cancer | |
Re: Phenotypic Characterisation of Immune Cell Infiltrates in Testicular Germ Cell Neoplasia | |
Re: Post-Chemotherapy Retroperitoneal Teratoma in Nonseminomatous Germ Cell Tumors: Do Predictive Factors Exist? Results from a National Multicenter Study | |
Re: Predictors of Sperm Recovery after Cryopreservation in Testicular Cancer | |
Re: presence of teratoma in orchiectomy specimen increases the need for postchemotherapy RPLND | |
Re: Prognostic Value of Programmed-Death-1 Receptor (PD-1) and its Ligand 1 (PD-L1) in Testicular Germ Cell Tumors | |
Re: Public perceptions of the harms and benefits of testicular cancer education: a qualitative study | |
Re: Radiation Exposure from Diagnostic Imaging in Young Patients with Testicular Cancer | |
Re: real-time tissue elastography for testicular lesion assessment | |
Re: Risk of Solid Cancer after Treatment of Testicular Germ Cell Cancer in the Platinum Era | |
Re: Role of Surgical Resection for Refractory Germ Cell Tumors. | |
Re: Sequelae of treatment in long-term survivors of testis cancer | |
Re: Serum Levels of MicroRNA371a-3p: | |
Re: Single-Nucleotide Polymorphism in the 5-α-Reductase Gene (SRD5A2) is Associated with Increased Prevalence of Metabolic Syndrome in Chemotherapy-Treated Testicular Cancer Survivors | |
Re: Spermatogenesis in Tumor-Bearing Testes in Germ Cell Testicular Cancer Patients | |
Re: testicular cancer in Europe and the USA: survival still rising among older patients | |
Re: Testicular cancer incidence to rise by 25% in Europe? Model-based predictions in 40 countries using population-based registry data | |
Re: Testicular Microlithiasis Imaging and Follow-up: Guidelines of the ESUR Scrotal Imaging Subcommittee | |
Re: Testicular Seminoma Clinical Stage 1: Treatment Outcome on a Routine Care Level. | |
Re: Testicular-Sparing Surgery for Bilateral or Monorchide Testicular Tumours: A Multicenter Study of Long-Term Oncological and Functional Results | |
Re: Testis-Sparing Surgery: Experience in 13 Patients with Oncologic and Functional Outcomes | |
Re: The clinical features and management of testicular germ cell tumours in patients aged 60 years and older | |
Re: The Rising Incidence of Testicular Cancer among Young Men in Canada, Data from 1971-2015 | |
Re: The Role of Social-Cognitive and Emotional Factors on Testicular Self-Examination | |
Re: The Role of Testis-Sparing Surgery in Children and Adolescents with Testicular Tumors | |
Re: towards the definition of the best management and prognostic factors of teratoma with malignant transformation: a single-institution case series and new proposal | |
Re: tumor marker kinetics predict outcome in patients with relapsed disseminated non-seminomatous germ-cell tumors | |
Re: Understanding the Crosstalk of Molecular Factors and Signaling Pathways Reveals Novel Biomarkers of Cisplatin Resistance in Testicular Germ Cell Tumors | |
Renal tumors: MR imaging-guided percutaneous cryotherapy--initial experience in 23 patients. | |
Retroperitoneal lymph node dissection in patients with high risk testicular cancer | |
Role of P53 and MDM2 in treatment response of human germ cell tumors | |
Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: receiver operating characteristic curves. | |
Solitary adrenal metastatic lesion in a patient with a history of prostate cancer. | |
Somatic mutations of KIT in familial testicular germ cell tumours | |
Surgical apgar outcome score: perioperative risk assessment for radical cystectomy | |
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo | |
Testicular function following chemotherapy | |
Testicular implants and patient satisfaction: a questionnaire-based study of men after orchidectomy for testicular cancer | |
Tumor detection by virtual cystoscopy with color mapping of bladder wall thickness | |
Unfavorable Intermediate-Risk Prostate Cancer and the Odds of Upgrading to Gleason 8 or Higher at Prostatectomy. | |
Unraveling androgen receptor interactomes by an array-based method: discovery of proto-oncoprotein c-Rel as a negative regulator of androgen receptor | |
Urologic cancer, c1983 (a.e.) | |
Urologic oncology | |
Using PSA, biopsy Gleason score, clinical stage, and the percentage of positive biopsies to identify optimal candidates for prostate-only radiation therapy | |
Variations in surgeon volume and use of pelvic lymph node dissection with open and minimally invasive radical prostatectomy | |
Words of wisdom. Re: Abiraterone and increased survival in metastatic prostate cancer | |
The zinc finger protein ras-responsive element binding protein-1 is a coregulator of the androgen receptor: implications for the role of the Ras pathway in enhancing androgenic signaling in prostate cancer |